SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950136-07-001701
Filing Date
2007-03-16
Accepted
2007-03-16 16:43:42
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 file1.htm 10-K 3605175
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCT FIRM file2.htm EX-23.1 2544
3 CERTIFICATION OF PRESIDENT & CEO file3.htm EX-31.1 13850
4 CERTIFICATION OF COO & EXE. VP, FINANCE file4.htm EX-31.2 13857
5 CERTIFICATION OF PRESIDENT AND CEO file5.htm EX-32.1 4293
6 CERTIFICATION OF COO & EXE. VP, FINANCE file6.htm EX-32.2 4351
7 ebox.gif GRAPHIC 58
8 xbox.gif GRAPHIC 63
9 spacer.gif GRAPHIC 43
  Complete submission text file 0000950136-07-001701.txt   3646303
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 07700676
SIC: 2834 Pharmaceutical Preparations